Syschem (India) Ltd. (BSE: 531173) is a Chandigarh-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹164 Cr, it ranks #2,815 by market cap among the 6,197 Indian listed companies on FinBizNet, and #58 of 86 in Medicinal Chemicals and Botanical Products. At ₹31.00 (as of 16 Nov 2026), the share price is 47.8% below its 52-week high of ₹59.39 and 7.6% above its 52-week low of ₹28.81. The share price is down 47.3% over one year and down 0.7% over three months.
| Current Price | ₹31.00 |
|---|---|
| Market Cap | ₹164 Cr |
| BSE Code | 531173 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 15.8 |
| Return on Equity | 10.23% |
| Return on Assets | 4.18% |
| 52-Week Range | ₹28.81 – ₹59.39 |
| 1-Year Price Change | -47.3% |
| 3-Month Price Change | -0.7% |
| Beta (1Y) | 0.64 |
| Headquarters | Chandigarh |
| Website | www.syschem.in |
Delivery averaged 77.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and is based in Chandigarh, India.
1. Chemicals-This segment manufactures ands sells pharmaceutical products. 2. Pharmaceutical Products-This segment engages in the manufacture and sale of monocorotophons, dichlorovos, pivaloyl chloride, bromine, and other chemicals and intermediates.
1. Pharmaceutical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,56,425 Cr | 39.5 | 14.72% | ₹16,199 Cr | +11.2% |
| Laurus Labs Ltd | ₹1,31,242 Cr | 145.6 | 17.74% | ₹2,206 Cr | +146.8% |
| Zydus Lifesciences Ltd | ₹1,19,651 Cr | 24.1 | 18.32% | ₹7,910 Cr | +26.0% |
| Dr.Reddys Lab | ₹1,15,464 Cr | 26.9 | 11.52% | ₹8,698 Cr | +14.5% |
| Cipla Limited | ₹1,14,712 Cr | 29.3 | 11.74% | ₹7,404 Cr | -7.6% |
| Mankind Pharma | ₹1,09,870 Cr | 57 | 12.45% | ₹4,338 Cr | +16.7% |
| Aurobindo Pharma Ltd. | ₹1,05,150 Cr | 30 | 9.93% | ₹10,263 Cr | +59.8% |
| Lupin Ltd | ₹92,087 Cr | 17.3 | 26.91% | ₹7,827 Cr | +0.4% |
| Syschem (India) Ltd. | ₹164 Cr | 15.8 | 10.23% | — | -47.3% |
Listed by market capitalisation. Ratios are shown for context only.
Syschem (India) Ltd. is trading at ₹31.00, with a market capitalisation of ₹164 Cr.
Syschem (India) Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Syschem (India) Ltd. has a P/E of 15.8 and a return on equity of 10.23%.
Syschem (India) Ltd. is listed on the BSE under the scrip code 531173.
Syschem (India) Ltd.'s share price is down 47.3% over one year and down 0.7% over three months. Its 52-week range is ₹28.81 to ₹59.39.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.